论文信息 - Ofatumumab plus HyperCVAD/HD‐MA induction leads to high rates of minimal residual disease negativity in patients with newly diagnosed mantle cell lymphoma: Results of a phase 2 study - 字舞流文

Ofatumumab plus HyperCVAD/HD‐MA induction leads to high rates of minimal residual disease negativity in patients with newly diagnosed mantle cell lymphoma: Results of a phase 2 study

P. Wallace | F. Hernandez-Ilizaliturri | S. Sait | J. Tario | C. Mavis | B. Baysal | P. Torka | S. Sundaram | O. S. Akhtar | A. Block | E. Przespolewski | A. Groman | N. Reddy | P. Ghione | A. Mohr | A. Kader | J. Nichols | I. Lund | J. Kostrewa | K. McWhite | J. Demarco | Michael Johnson | A. Darrall | Rosh-Neke Thomas-Talley | V. Neppalli | Alan Hutson | O. Akhtar | Alan D. Hutson | Jenna Nichols